Skip to main content
IQV logo

IQV · Iqvia Holdings Inc. · Earnings Call Transcripts & Audio

Track IQV — free
$268.85 -0.14 (-0.05%) At close · Sep 30
Market Cap
$45.12B
Shares
166.90M
Volume · Sep 30 1.53M Avg daily vol (3M) 1.45M

Iqvia Holdings Inc. Earnings Call Transcripts

Quarterly earnings calls for Iqvia Holdings Inc. (IQV), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q3
2026-10-27
Iqvia Holdings Inc. (IQV) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-07-28
Iqvia Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript
Confident tone Raised full-year guidance Q2 financial beat vs guidance Commercial solutions growth acceleration
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Iqvia Holdings Inc. (IQV) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Iqvia Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript
Confident tone R&D Solutions / Clinical bookings and backlog Financial results and guidance Segment reporting restructuring
Revenue
$4.15B
▲ 8.4% YoY
Diluted EPS
$1.61
▲ 15% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-12
Iqvia Holdings Inc. (IQV) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-09
Iqvia Holdings Inc. (IQV) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-05
Iqvia Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript
Confident tone Commercial performance Organizational simplification in 2026 Margin and pass-throughs
Revenue
$4.36B*
▲ 10.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Iqvia Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript
Confident tone R&D Solutions and Phase I expansion TAS and drug launches Clinical bookings and backlog
Revenue
$4.10B
▲ 5.2% YoY
Diluted EPS
$1.93
▲ 24.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-22
Iqvia Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript
Positive tone Quarterly financial results TAS / commercial business Market environment and policy uncertainty
Revenue
$4.02B
▲ 5.3% YoY
Diluted EPS
$1.54
▼ 21.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Iqvia Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript
Positive tone R&DS clinical environment Backlog and demand metrics FSP vs full service mix
Revenue
$3.83B
▲ 2.5% YoY
Diluted EPS
$1.40
▼ 10.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Iqvia Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript
Positive tone R&DS Demand and Cancellations TAS Segment Recovery Guidance and 2025 Outlook
Revenue
$3.96B*
▲ 2.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Iqvia Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript
Positive tone Mega-trial delays and cancellations TAS (short-cycle) recovery Backlog and book-to-bill
Revenue
$3.90B
▲ 4.3% YoY
Diluted EPS
$1.55
▼ 4.9% YoY
Gross margin
23.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-22
Iqvia Holdings Inc. (IQV) Q2 2024 Earnings Call Transcript
Positive tone TAS / Technology & Analytics R&DS / Clinical Bookings and Backlog Capital Allocation and M&A Pipeline
Revenue
$3.81B
▲ 2.3% YoY
Diluted EPS
$1.97
▲ 23.9% YoY
Gross margin
22.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Iqvia Holdings Inc. (IQV) Q1 2024 Earnings Call Transcript
Positive tone CNS cancellation and revenue impact Strategic partnerships and technology wins R&D clinical demand and backlog
Revenue
$3.74B
▲ 2.3% YoY
Diluted EPS
$1.56
▲ 2% YoY
Gross margin
22.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-14
Iqvia Holdings Inc. (IQV) Q4 2023 Earnings Call Transcript
Positive tone 2024 financial guidance and headwinds R&D Solutions bookings and backlog Pricing pressure and negotiation dynamics
Revenue
$3.87B*
▲ 3.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Iqvia Holdings Inc. (IQV) Q3 2023 Earnings Call Transcript
Revenue
$3.74B
▲ 4.9% YoY
Diluted EPS
$1.63
▲ 9.4% YoY
Gross margin
23.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Iqvia Holdings Inc. (IQV) Q2 2023 Earnings Call Transcript
Revenue
$3.73B
▲ 5.3% YoY
Diluted EPS
$1.59
▲ 18.7% YoY
Gross margin
22.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Iqvia Holdings Inc. (IQV) Q1 2023 Earnings Call Transcript
Revenue
$3.65B
▲ 2.4% YoY
Diluted EPS
$1.53
▼ 8.9% YoY
Gross margin
22.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-10
Iqvia Holdings Inc. (IQV) Q4 2022 Earnings Call Transcript
Revenue
$3.74B*
▲ 2.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Iqvia Holdings Inc. (IQV) Q3 2022 Earnings Call Transcript
Revenue
$3.56B
▲ 5% YoY
Diluted EPS
$1.49
▲ 11.2% YoY
Gross margin
22.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Iqvia Holdings Inc. (IQV) Q2 2022 Earnings Call Transcript
Revenue
$3.54B
▲ 3% YoY
Diluted EPS
$1.34
▲ 48.9% YoY
Gross margin
22.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Iqvia Holdings Inc. (IQV) Q1 2022 Earnings Call Transcript
Revenue
$3.57B
▲ 4.7% YoY
Diluted EPS
$1.68
▲ 54.1% YoY
Gross margin
22.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Iqvia Holdings Inc. (IQV) Q4 2021 Earnings Call Transcript
Revenue
$3.64B*
▲ 10.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Iqvia Holdings Inc. (IQV) Q3 2021 Earnings Call Transcript
Revenue
$3.39B
▲ 21.7% YoY
Diluted EPS
$1.34
▲ 157.7% YoY
Gross margin
21.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Iqvia Holdings Inc. (IQV) Q2 2021 Earnings Call Transcript
Revenue
$3.44B
▲ 36.4% YoY
Diluted EPS
$0.90
Gross margin
20.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Iqvia Holdings Inc. (IQV) Q1 2021 Earnings Call Transcript
Revenue
$3.41B
▲ 23.8% YoY
Diluted EPS
$1.09
▲ 159.5% YoY
Gross margin
21.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-10
Iqvia Holdings Inc. (IQV) Q4 2020 Earnings Call Transcript
Revenue
$3.30B
▲ 13.9% YoY
Diluted EPS
$0.61
▲ 577.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-20
Iqvia Holdings Inc. (IQV) Q3 2020 Earnings Call Transcript
Revenue
$2.79B
▲ 0.6% YoY
Diluted EPS
$0.52
▲ 79.3% YoY
Gross margin
21.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-22
Iqvia Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript
Revenue
$2.52B
▼ 8% YoY
Diluted EPS
$-0.12
▼ 140% YoY
Gross margin
17.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Iqvia Holdings Inc. (IQV) Q1 2020 Earnings Call Transcript
Revenue
$2.75B
▲ 2.6% YoY
Diluted EPS
$0.42
▲ 44.8% YoY
Gross margin
19.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-12
Iqvia Holdings Inc. (IQV) Q4 2019 Earnings Call
Revenue
$2.90B
▲ 7.7% YoY
Diluted EPS
$0.09
▼ 73.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–31 of 31 earnings calls
Key facts CIK 1478242 CUSIP 46266C105 13F (30d) 28 filings 16 filers Visit website Investor relations